UBS Group AG - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 66 filers reported holding VYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$8,201
+310.0%
54,674
+422.8%
0.00%
Q3 2022$2,000
-50.0%
10,457
-0.1%
0.00%
Q2 2022$4,00010,469
+4005.5%
0.00%
Q1 2022$0255
+4.9%
0.00%
Q4 2021$0
-100.0%
243
-94.0%
0.00%
Q3 2021$6,000
-76.9%
4,044
-44.5%
0.00%
Q2 2021$26,000
-43.5%
7,283
+9.4%
0.00%
Q1 2021$46,0006,6570.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders